Citations

Showing 10 of 108104 citations.

Oral Glucose Tolerance Test Measures of First-phase Insulin Response and Their Predictive Ability for Type 1 Diabetes
Baidal, David A. , Warnock, Megan, Geyer, Susan, Marks, Jennifer B. , Moran, Antoinette , Sosenko, Jay M. , Xu, Ping , Evans‐Molina, Carmella

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | May 7, 2022 | Volume: 107 | Issue: 8 | Pages: e3273-e3280

10.1210/clinem/dgac285 | PMID 35524749 Get It

Abstract Context Decreased first-phase insulin response (FPIR) during intravenous glucose tolerance testing (IVGTT) is an early indicator of β-cell dysfunction and predictor of type 1 diabetes (T1D). Objective Assess whether oral glucose tolerance test (OGTT) measures could serve as FPIR alternatives in their ability to predict T1D in autoantibody positive (Aab+) subjects. Design OGTT and IVGTT were performed within 30 days of each other. Eleven OGTT variables were evaluated for (1) correlation with FPIR and (2) T1D prediction. Setting Type 1 Diabetes TrialNet “Oral Insulin for Prevention of Diabetes in Relatives at Risk for T1D” (TN-07) and Diabetes Prevention Trial-Type 1 Diabetes (DPT-1) studies clinical sites. Patients TN-07 (n = 292; age 9.4 ± 6.1 years) and DPT-1 (n = 194; age 15.1 ± 10.0 years) Aab + relatives of T1D individuals. Main outcome measures (1) Correlation coefficients of OGTT measures with FPIR and (2) T1D prediction at 2 years using area under receiver operating characteristic (ROCAUC) curves. Results Index60 showed the strongest correlation in DPT-1 (r = -0.562) but was weaker in TN-07 (r = -0.378). C-peptide index consistently showed good correlation with FPIR across studies (TN-07, r = 0.583; DPT-1, r = 0.544; P < 0.0001). Index60 and C-peptide index had the highest ROCAUCs for T1D prediction (0.778 vs 0.717 in TN-07 and 0.763 vs 0.721 in DPT-1, respectively; P = NS), followed by FPIR (0.707 in TN-07; 0.628 in DPT-1). Conclusions C-peptide index was the strongest measure to correlate with FPIR in both studies. Index60 and C-peptide index had the highest predictive accuracy for T1D and were comparable. OGTTs could be considered instead of IVGTTs for subject stratification in T1D prevention trials.
Pyoderma gangrenosum‐like skin ulceration in antineutrophil cytoplasmic antibody‐associated vasculitis: a retrospective case series
Shakshouk, Hadir , Gibson, Lawrence E. , Shakshouk, H

Mayo Clinic

Clinical and Experimental Dermatology | May 7, 2022 | Volume: 47 | Issue: 9 | Pages: 1716-1719

10.1111/ced.15251 | PMID 35524738 Get It

Foot evaluation via telephone and video virtual medical visits
Applewhite, Andres I. , Pujalte, George , Denay, Keri L., Odom, Mitchell , Arizpe, Azael, Albano‐Aluquin, Shirley , Kinaszczuk, Anja M., Aiyer, Amiethab A. , Pujalte, George G A , Tu, Priscilla

Mayo Clinic

Musculoskeletal Care | May 7, 2022 | Volume: 20 | Issue: 4 | Pages: 772-783

10.1002/msc.1642 | PMID 35524702 Get It

AbstractBackgroundTelemedicine plays a very important role in our society by allowing providers to treat patients who do not have easy access to a healthcare facility, especially in the setting of the COVID‐19 pandemic.ObjectiveWe aimed to create an extensive, yet concise guide for medical providers to virtually evaluate patients with foot concerns.MethodsThis article outlines how to conduct a well‐planned virtual consultation with specific questions, instructions, and examination manoeuvres to navigate musculoskeletal foot problems.ConclusionWith this narrative review, we have provided a guide with suggestions, questions and interpretations of answers to help physicians new to the practice of telemedicine have successful virtual encounters with patients suffering from foot musculoskeletal ailments.
Equal representation of low and high Fitzpatrick skin type images in a supplemental curriculum does not improve overall high Fitzpatrick diagnostic accuracy. A prospective study
Mullen, Barbara , Gorman, Benjamin G. , Soares, Alexa A. , Jin, Mauricio F. , Melson, Valerie A. , Campbell, Elliott H. , Vidal, Nahid Y. , Mullen, Barbara L

Mayo Clinic

International Journal of Dermatology | May 7, 2022 | Volume: 62 | Issue: 4 | Pages: No page available

10.1111/ijd.16211 | PMID 35524501 Get It

Nano-Sized Extracellular Vesicles Secreted from GATA-4 Modified Mesenchymal Stem Cells Promote Angiogenesis by Delivering Let-7 miRNAs
Wang, Min , Wang, Yigang , Xu, Meifeng , Wang, Min , Gong, Min , Xu, Jie , Yu, Bin , Liu, Min , Ashraf, Muhammad

Mayo Clinic

Cells | May 7, 2022 | Volume: 11 | Issue: 9 | Pages: 1573

10.3390/cells11091573 | PMID 35563879 Get It

We demonstrated previously that extracellular vesicles (EVs) released from mesenchymal stem cells (MSCs) play a critical role in angiogenesis. Here, we examine whether this pro-angiogenic efficacy is enhanced in EVs derived from MSCs overexpressing GATA-4 (MSCGATA−4). Methods and Results. EVs were isolated from MSCGATA-4 (EVGATA-4) and control MSCs transduced with an empty vector (EVnull). EVs from both cell types were of the same size and displayed similar molecular markers. Compared with EVnull, EVGATA-4 increased both a tube-like structure formation and spheroid-based sprouting of human umbilical vein endothelial cells (HUVECs). The EVGATA-4 increased the numbers of CD31-positive cells and hemoglobin content inside Matrigel plugs subcutaneously transplanted into mice for 2 weeks. Moreover, EVGATA-4 encapsulated higher levels of let-7 family miRs compared to EVnull. The transfer of exosomal let-7 miRs into HUVECs was recorded with an accompanied down-regulation of thrombospondin-1 (THBS1) expression, a major endogenous angiogenesis inhibitor. The loss-and-gain of function studies of let-7 miRs showed that let-7f knockdown significantly decreased EVGATA-4-mediated vascularization inside Matrigel plugs. In contrast, let-7f overexpression promoted HUVEC migration and tube formation. Conclusion. Our results indicate that EVs derived from genetically modified MSCs with GATA-4 overexpression had increased pro-angiogenic capacity due to the delivery of let-7 miRs that targeted THBS1 in endothelial cells.
Treatment of chronic migraine with medication overuse: A perspective
Schwedt, Todd J. , Robert, Teri, Dodick, David W. , Dodick, David W , Schwedt, Todd J

Mayo Clinic

Headache: The Journal of Head and Face Pain | May 7, 2022 | Volume: 62 | Issue: 5 | Pages: 642-644

10.1111/head.14314 | PMID 35524461 Get It

Endoplasmic reticulum stress in liver diseases
Ajoolabady, Amir , Kaplowitz, Neil , Lebeaupin, Cynthia , Kaufman, Randal J. , Malhi, Harmeet , Ren, Jun , Malhi, Harmeet , Ren, Jun , Kroemer, Guido

Mayo Clinic

Hepatology | May 7, 2022 | Volume: 77 | Issue: 2 | Pages: 619-639

10.1002/hep.32562 | PMID 35524448 Get It

The endoplasmic reticulum (ER) is an intracellular organelle that fosters the correct folding of linear polypeptides and proteins, a process tightly governed by the ER‐resident enzymes and chaperones. Failure to shape the proper 3‐dimensional architecture of proteins culminates in the accumulation of misfolded or unfolded proteins within the ER, disturbs ER homeostasis, and leads to canonically defined ER stress. Recent studies have elucidated that cellular perturbations, such as lipotoxicity, can also lead to ER stress. In response to ER stress, the unfolded protein response (UPR) is activated to reestablish ER homeostasis (“adaptive UPR”), or, conversely, to provoke cell death when ER stress is overwhelmed and sustained (“maladaptive UPR”). It is well documented that ER stress contributes to the onset and progression of multiple hepatic pathologies including NAFLD, alcohol‐associated liver disease, viral hepatitis, liver ischemia, drug toxicity, and liver cancers. Here, we review key studies dealing with the emerging role of ER stress and the UPR in the pathophysiology of liver diseases from cellular, murine, and human models. Specifically, we will summarize current available knowledge on pharmacological and non‐pharmacological interventions that may be used to target maladaptive UPR for the treatment of nonmalignant liver diseases.
Relationship of iothalamate clearance and NRM in patients receiving fludarabine and melphalan reduced-intensity conditioning
Kutzke, Jade L. , Merten, Julianna A., Pawlenty, Amanda G. , Frazee, Erin N. , Bartoo, Gabe T., Mara, Kristin C. , Litzow, Mark R. , Shah, Meera , Mangaonkar, Abhishek A. , Shah, Mithun V , Leung, Nelson , Sierzchulski, Amanda G. , Mara, Kristin C , Hogan, William J. , Leung, Nelson , Alkhateeb, Hassan B.

Mayo Clinic

Blood Advances | May 6, 2022 | Volume: 6 | Issue: 13 | Pages: 3844-3849

10.1182/bloodadvances.2021006395 | PMID 35522968 Get It

Abstract The reduced-intensity conditioning regimen, fludarabine and melphalan, is frequently used in allogeneic hematopoietic stem cell transplantation (HSCT). Melphalan and the active metabolite of fludarabine, F-ara-A, are excreted via the kidneys. Existing methods to assess clearance in this setting are based on serum creatinine, which has known limitations for glomerular filtration rate (GFR) estimation in patients with malignancy. Measured GFR (mGFR) may better predict drug dosing to mitigate toxicity and increase the chances of successful engraftment. The primary objective of this study was to assess the association between mGFR and risk for nonrelapse mortality (NRM) in patients who have undergone allogeneic HSCT receiving conditioning with fludarabine and melphalan. In the 109 included patients, mGFR <65 mL/min/1.73 m2 predicted a significantly higher rate of overall NRM (hazard ratio [HR], 2.13; 95% confidence interval [CI], 1.03-4.35; P = 04) and 1-year incidence of infection (HR, 2.63; 95% CI, 1.54-4.55; P < .001) in addition to a significantly lower 2-year survival (P = .019). Kidney function estimated via estimated GFR (eGFR) and estimated creatinine clearance did not correlate with posttransplant outcomes. These results suggest that mGFR is a promising approach for assessing clearance in patients who have undergone allogeneic HSCT and may be preferred to standard creatinine-based eGFR strategies.
A Tool for Differential Diagnosis of Childhood Apraxia of Speech and Dysarthria in Children: A Tutorial
Iuzzini-Seigel, Jenya , Allison, Kristen M. , Stoeckel, Ruth , Allison, Kristen , Stoeckel, Ruth , Iuzzini-Seigel, Jenya

Mayo Clinic

Language, Speech, and Hearing Services in Schools | May 6, 2022 | Volume: 53 | Issue: 4 | Pages: 926-946

10.1044/2022_lshss-21-00164 | PMID 35523425 Get It

Purpose: While there has been mounting research centered on the diagnosis of childhood apraxia of speech (CAS), little has focused on differentiating CAS from pediatric dysarthria. Because CAS and dysarthria share overlapping speech symptoms and some children have both motor speech disorders, differential diagnosis can be challenging. There is a need for clinical tools that facilitate assessment of both CAS and dysarthria symptoms in children. The goals of this tutorial are to (a) determine confidence levels of clinicians in differentially diagnosing dysarthria and CAS and (b) provide a systematic procedure for differentiating CAS and pediatric dysarthria in children. Method: Evidence related to differential diagnosis of CAS and dysarthria is reviewed. Next, a web-based survey of 359 pediatric speech-language pathologists is used to determine clinical confidence levels in diagnosing CAS and dysarthria. Finally, a checklist of pediatric auditory–perceptual motor speech features is presented along with a procedure to identify CAS and dysarthria in children with suspected motor speech impairments. Case studies illustrate application of this protocol, and treatment implications for complex cases are discussed. Results: The majority (60%) of clinician respondents reported low or no confidence in diagnosing dysarthria in children, and 40% reported they tend not to make this diagnosis as a result. Going forward, clinicians can use the feature checklist and protocol in this tutorial to support the differential diagnosis of CAS and dysarthria in clinical practice. Conclusions: Incorporating this diagnostic protocol into clinical practice should help increase confidence and accuracy in diagnosing motor speech disorders in children. Future research should test the sensitivity and specificity of this protocol in a large sample of children with varying speech sound disorders. Graduate programs and continuing education trainings should provide opportunities to practice rating speech features for children with dysarthria and CAS. Supplemental Material: https://doi.org/10.23641/asha.19709146
KLF11 Is a Novel Endogenous Protectant against Renal Ischemia-Reperfusion Injury
Nath, Karl A. , Singh, Raman Deep , Croatt, Anthony J., Ackerman, Allan W., Grande, Joseph P. , Khazaie, Khasayarsha, Chen, Y. Eugene , Zhang, Jifeng

Mayo Clinic

Kidney360 | May 6, 2022 | Volume: 3 | Issue: 8 | Pages: 1417-1422

10.34067/kid.0002272022 | PMID 36176648 Get It